Condition
Hypopharynx Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Hypopharynx Cancer clinical trials that are recruiting, at sites in 7 countries (most in United States (3), China (1), France (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 7Countries
Newest Hypopharynx Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sacituzumab govitecan plus cetuximab for recurrent or metastatic head and neck squamous cell cancer | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Jul 14, 2025 |
| Methotrexate with erlotinib and celecoxib for recurrent or metastatic head and neck cancer in rural Midwest patients | Phase 2 | Rochester, Minnesota | Recruiting | May 30, 2025 |
| Treatment for head and neck cancer using tailored radiotherapy and ATRA | Phase 3 | Lyon, France and 7 other locations | Recruiting | Nov 26, 2024 |
| Combining targeted radiation with immunotherapy and chemotherapy for advanced laryngeal and hypopharyngeal cancer | Phase 2 | Guangzhou, Guangdong | Recruiting | Sep 24, 2024 |
| Care patterns for elderly patients with head and neck cancer receiving radiotherapy | — | Baltimore, Maryland and 17 other locations | Recruiting | Apr 20, 2022 |
All recruiting trials (5)
-
Sacituzumab govitecan plus cetuximab for recurrent or metastatic head and neck squamous cell cancer
This trial will test whether combining sacituzumab govitecan with cetuximab works and is safe for people whose head and neck squamous cell cancer has returned or spread after prior immunotherapy.
-
Methotrexate with erlotinib and celecoxib for recurrent or metastatic head and neck cancer in rural Midwest patients
This trial tests whether combining methotrexate, erlotinib, and celecoxib can help adults in the rural Midwest whose head and neck cancer has returned or spread.
-
Treatment for head and neck cancer using tailored radiotherapy and ATRA
This study is testing if a new combination of a cancer drug called ATRA with personalized radiotherapy can help people with certain types of head and neck cancer live longer and feel better.
-
Combining targeted radiation with immunotherapy and chemotherapy for advanced laryngeal and hypopharyngeal cancer
This study is testing a new treatment that combines targeted radiation with immunotherapy and chemotherapy to see if it can help people with advanced laryngeal and hypopharyngeal cancer while preserving their voice box.
-
Care patterns for elderly patients with head and neck cancer receiving radiotherapy
This study is looking at how well elderly patients with advanced head and neck cancer do with radiation treatment and chemotherapy to see if it helps them live longer and stay healthier.
Related topics
Quick answers
How many Hypopharynx Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (3 trials), China (1 trial), France (1 trial), Cyprus (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.